XML 58 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Compensation (Tables)
12 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
 Fiscal Year Ended June 30,
 202320222021
 (in thousands)
Share-based compensation related to:
Equity classified stock options$1,426 $1,848 $1,332 
Equity classified restricted stock9,793 9,815 6,707 
Total share-based compensation$11,219 $11,663 $8,039 
Weighted Average Assumptions for the Options Granted During the Following Fiscal Years The Company used the following weighted-average assumptions for the options granted in fiscal year ended June 30, 2021:
 Fiscal Year Ended June 30,
 2021
Expected term5 years
Expected volatility42.78%
Risk-free interest rate0.36%
Dividend yield0.00%
Weighted-average fair value per option$9.01
Stock Option Plans
A summary of activity under our stock option plans is presented below:

 Fiscal Year Ended June 30, 2023
 OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Life
Aggregate
Intrinsic
Value
Outstanding, beginning of year1,123,099 $32.23 
Granted during the period— — 
Exercised during the period(36,435)25.00 
Canceled, forfeited, or expired during the period(59,993)27.70 
Outstanding, end of year1,026,671 32.76 4.57$2,113,985 
Vested and expected to vest at June 30, 20231,026,460 32.76 4.57$2,112,871 
Exercisable, end of year855,834 $34.28 4.01$— 
Unvested Shares
A summary of the status of the Company’s shares subject to unvested options is presented below:
 Fiscal Year Ended June 30, 2023
 OptionsWeighted Average Exercise PriceWeighted Average
Grant Date 
Fair Value
Unvested, beginning of year384,638 $25.16 $9.08 
Granted— — — 
Vested(171,926)25.11 9.06 
Canceled or forfeited(41,875)25.51 9.30 
Unvested, end of year170,837 $25.12 $9.06 
Stock Options Outstanding The following table summarizes information about stock options outstanding and exercisable as of June 30, 2023:
 Options OutstandingOptions Exercisable
Range of Exercise PricesShares
  Outstanding
Weighted
Average
Remaining
  Contractual Life
Weighted Average
Exercise
Price
Number ExercisableWeighted Average
Exercise
Price
$22.27 - $26.38
363,233 7.3824.53 231,673 24.55 
$26.38 - $30.49
119,021 7.4027.14 79,744 27.14 
$30.49 - $34.60
57,799 4.4434.35 57,799 34.35 
$34.60 - $38.71
207,169 2.8337.71 207,169 37.71 
$38.71 - $42.82
279,449 1.0241.83 279,449 41.83 
1,026,671 4.57$32.76 855,834 $34.28 
Restricted Stock Outstanding
During the fiscal year ended June 30, 2023, the Company granted 518,987 shares of restricted stock to employees and non-employee directors, all of which were issued in the form of RSUs:
 Fiscal Year Ended June 30, 2023
 Shares
granted
Date grantedGrant date
fair value
Vesting period
Employees
Certain employees based on performance346,059 August 26, 2022$28.66 
Annually over 4 years
Certain employees based on performance58,323 August 26, 2022$28.66 
Annually over 3 years
Certain employees based on performance58,323 August 26, 2022$27.92 
Annually over 3 years
Certain employees based on performance815 December 1, 2022$30.70 
Annually over 4 years
Certain employees based on hire13,067 June 1, 2023$28.70 
Annually over 4 years
Non-Employee Directors
Certain Directors42,400 August 26, 2022$28.66 
12 months

A summary of the status of the Company’s outstanding restricted stock is presented below:

 Fiscal Year Ended June 30, 2023
 SharesWeighted-Average
Grant Date Fair
Value
Outstanding, beginning of year639,342 $32.04 
Granted during the period518,987 28.58 
Vested during the period(224,062)30.56 
Cancelled, forfeited, or expired during the period(44,357)31.29 
Outstanding, end of year889,910 $30.43